As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...